RecruitingNCT05243966

Myriad™ Augmented Soft Tissue Reconstruction Registry

Registry of Myriad™ Utilization in Soft Tissue Reconstruction Procedures

Sponsor

Aroa Biosurgery Limited

Enrollment

800 participants

Start Date

Jan 10, 2022

Study Type

OBSERVATIONAL

Conditions

pressure injury pilonidal sinus Hidradenitis Suppurativa Anal Fistula Necrotizing Soft Tissue Infection Abdominal Wound Dehiscence Lower Extremity Wound

Summary

This is an observational study designed to evaluate the safety and clinical outcomes of Myriad™ in soft tissue reconstruction procedures. The study will enroll participants who are undergoing a surgical procedure, where the attending physician will use Myriad™ as part of the surgical intervention.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Myriad Matrix™ and Myriad Morcells™ for people with abdominal wound dehiscence, anal fistula, and other related conditions. The study is currently recruiting participants at 13 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMyriad Matrix™ and Myriad Morcells™

Ovine forestomach matrix sheet graft and morselized extracellular matrix

Locations(15)

The Diane & Bruce Halle Arizona Burn Center at Valleywise Health

Phoenix, Arizona, United States

Surgery Group LA

Los Angeles, California, United States

Associates in Medicine & Surgery

Fort Myers, Florida, United States

Asencion Sacred Heart

Pensacola, Florida, United States

Northeast Georgia Medical Center, Inc.

Gainesville, Georgia, United States

University of IOWA Health Care

Iowa City, Iowa, United States

University Medical Center

New Orleans, Louisiana, United States

Ochsner Baptist Medical Center

New Orleans, Louisiana, United States

Sinai Hospital of Baltimore

Baltimore, Maryland, United States

Nuvance Health Vassar Brothers Medical Center

Poughkeepsie, New York, United States

Moses H Cone Memorial Hospital Operating Corporation

Greensboro, North Carolina, United States

Ohio State University Wexner Medical Center

Columbus, Ohio, United States

Lancaster General Hospital

Lancaster, Pennsylvania, United States

Tower Health Reading Hospital

West Reading, Pennsylvania, United States

The Medical College of Wisconsin

Milwaukee, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05243966

Related Trials

ENVELOP: Wound Care Following Pilonidal Sinus Surgery

NCT0664729010 locations

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

NCT0688819314 locations

A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa

NCT0692185018 locations

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

NCT076654374 locations

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

NCT05889182285 locations